These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33742719)

  • 1. Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of β-catenin: Evidence of inhibition of Wnt/β-catenin signaling as an important antitumor mechanism of microtubule-targeting agents.
    Kumari A; Shriwas O; Sisodiya S; Santra MK; Guchhait SK; Dash R; Panda D
    FASEB J; 2021 Apr; 35(4):e21539. PubMed ID: 33742719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex determining region Y-box 9 induced microtubule formation and epithelial⁃mesenchymal transition in human oral squamous cell carcinoma CAL27 cells.
    Huang S; Zhang QY; He AE; Li HB; Zhang ZX
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):74-80. PubMed ID: 33723940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.
    Oak ASW; Bocheva G; Kim TK; Brożyna AA; Janjetovic Z; Athar M; Tuckey RC; Slominski AT
    Anticancer Res; 2020 May; 40(5):2467-2474. PubMed ID: 32366390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
    Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
    BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Roles of Wnt-1, beta-catenin and adenomatous polyposis coli in the differentiation and proliferation of oral squamous cell carcinoma].
    Zhang WM; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):491-4. PubMed ID: 16329837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
    Vidya Priyadarsini R; Senthil Murugan R; Nagini S
    Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.
    Jamal B; Sengupta PK; Gao ZN; Nita-Lazar M; Amin B; Jalisi S; Bouchie MP; Kukuruzinska MA
    Oral Oncol; 2012 Jun; 48(6):523-9. PubMed ID: 22341307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
    Zheng TL; Cen K
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.